-+ 0.00%
-+ 0.00%
-+ 0.00%

US judge consolidates Quantum BioPharma stock-manipulation suits against CIBC, RBC

PUBT·10/08/2026 12:03:08
Listen to the news
US judge consolidates Quantum BioPharma stock-manipulation suits against CIBC, RBC
  • A US federal judge in Manhattan consolidated Quantum BioPharma’s lawsuit with a shareholder class action alleging stock-price manipulation.
  • The court appointed Grant & Eisenhofer as lead counsel for the consolidated class action.
  • The suits accuse CIBC, RBC, or their customers of using “spoofing” to manipulate the stock from Jan. 1, 2020, to Aug. 15, 2024.
  • The class action alleges investor harm for shareholders who sold securities from Jan. 6, 2021, to Oct. 15, 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-006529), on October 08, 2026, and is solely responsible for the information contained therein.